A competition-based assay for the screening of species-specific antibiotics

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 1, 2009, Pages 62-68

  Granieri, Lucia ^a,b   Miller, Oliver J ^a,b   Griffiths, Andrew D ^a,b   Merten, Christoph A ^a,b,c  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b CNRS   (France)

^c UNIVERSITÉ LOUIS PASTEUR   (France)

Author keywords

Cytotoxicity; Drug development; High throughput assays; Staphylococci; Staphylococcus aureus

Indexed keywords

SODIUM AZIDE; STREPTOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CELL VIABILITY; COCULTURE; COLONY FORMING UNIT GEMM; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG TARGETING; FLUORESCENCE ANALYSIS; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; INTRASPECIFIC COMPETITION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; REPRODUCIBILITY; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CELL LINE; COCULTURE TECHNIQUES; COLONY COUNT, MICROBIAL; DRUG EVALUATION, PRECLINICAL; HUMANS; SODIUM AZIDE; STAPHYLOCOCCUS AUREUS; STREPTOMYCIN;

EID: 67249131907     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp137     Document Type: Article

References (15)

1. The World Health Organization. The World Health Report 2004 - Changing History. Geneva: The World Health Organization, 2004; 120-5.
2. Bancroft EA. Antimicrobial resistance - it's not just for hospitals. JAMA 2007; 298: 1803-4.
3. Brown ED, Wright GD. New targets and screening approaches in antimicrobial drug discovery. Chem Rev 2005; 105: 759-74.
4. Fuente RDL, Sonawane ND, Arumainayagam D et al. Small molecules with antimicrobial activity against E. coli and P. aeruginosa identified by high-throughput screening. Br J Pharmacol 2006; 149: 551-9.
5. Srivastava R, Deb DK, Srivastava KK et al. Green fluorescent protein as a reporter in rapid screening of antituberculosis compounds in vitro and in macrophages. Biochem Biophys Res Commun 1998; 253: 431-6.
6. Arain TM, Resconi AE, Hickey MJ et al. Bioluminescence screening in vitro assays for high-volume antimycobacterial drug discovery. Antimicrob Agents Chemother 1996; 40: 1536-41.
7. Tarrand JJ, Gröschel DH. Evaluation of the bactec radiometric method for detection of 1% resistant populations of Mycobacterium tuberculosis. J Clin Microbiol 1985; 21: 941-6.
8. DeVito JA, Mills JA, Liu VG et al. An array of target-specific screening strains for antibacterial discovery. Nat Biotechnol 2002; 20: 478-83.
9. Greis KD, Zhou S, Siehnel R et al. Development and validation of a whole-cell inhibition assay for bacterial methionine aminopeptidase by surface-enhanced laser desorption ionization-time of flight mass spectrometry. Antimicrob Agents Chemother 2005; 49: 3428-34.
10. Zhang JH, Chung TDK, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999; 4: 67-73.
11. Zakaria Z, Sreenivasan S, Mohamad M. Antimicrobial activity of Piper ribesoides root extract against Staphylococcus aureus. JABS 2007; 1: 87-90.
12. Zenilman JM, Miller MH, Mandel LJ. In vitro studies simultaneously examining effect of oxacillin on uptake of radiolabeled streptomycin and on associated bacterial lethality in Staphylococcus aureus. Antimicrob Agents Chemother 1986; 30: 877-82.
13. Kodama F, Fukushima K, Umeda M. Chromosome aberrations induced by clinical medicines. J Toxicol Sci 1980; 5: 141-50.
14. Lemeire K, Merris VV, Cortvrindt R. The antibiotic streptomycin assessed in a battery of in vitro tests for reproductive toxicology. Toxicol In Vitro 2007; 21: 1348-53.
15. Oda Y, Owa T, Sato T et al. Quantitative chemical proteomics for identifying candidate drug targets. Anal Chem 2003; 75: 2159-65.